The Delay in The Diagnosis of Lung Cancer Due to Misdiagnosis as Pulmonary Tuberculosis

Authors

  • Jatu Aviani Universitas Sebelas Maret
  • Satria Maulana EH Universitas Sebelas Maret
  • Ita Haryatie Universitas Sebelas Maret
  • Farih Raharjo Universitas Sebelas Maret
  • Yusup Subagio Sutanto Universitas Sebelas Maret
  • Ana Rima Setijadi Universitas Sebelas Maret

DOI:

https://doi.org/10.36497/jri.v37i4.83

Keywords:

pulmonary tuberculosis, lung cancer, misdiagnosis

Abstract

Background: Lung cancer and pulmonary tuberculosis (TB) are global health problem. Similarity of symptoms of both made misdiagnose of lung cancer as TB and treated with Anti Tuberculosis Treatment (ATT). Evaluation of ATT often inaccurate, causing late diagnosis of lung cancer. This study aimed is to determine the lung cancer percentage with delayed diagnosis due giving of ATT for >1 month. Methods: A prospective descriptive study was performed from January 2014-February 2016 in Dr. Moewardi Hospital, Surakarta taken from the patient's medical record. Results: As much 293 patients with lung cancer consisted of 188 males (64.4%) and 105 females (35.8%) with the average age was 57 years old. The types of the lung cancer were non-small cell lung carcinoma (NSCLC) consisted of adenocarcinoma 195 subjects (66.6%), squamous cell carcinoma 65 subjects (22.2%), large cell carcinoma 23 subjects (7.8%) and neuroendocrine carcinoma 4 subjects (1.4%). The stages of the NSCLC were stage I (0%), II (0%), IIIa (0%), IIIb (11.7%) and IV (88.3%). Among 293 lung cancer patients, 89 subjects (30.4%) were diagnosis as pulmonary TB. Two subjects (2.2%) of 89 subjects were truly pulmonary TB while the rest 87 subjects were not pulmonary TB and had ATT for average 12 weeks with the longest period was 16 weeks. The ATT duration >1 month was 76.4%. Conclusions: Percentage of lung cancer patients with ATT before being referred to dr. Moewardi hospital were 30.4% of 293 lung cancer patients while 68 subjects (76.4%) of whom had received ATT >1 month. (J Respir Indo. 2017; 37(4): 288-92)

Downloads

Download data is not yet available.

Author Biographies

  • Jatu Aviani, Universitas Sebelas Maret
    Departemen Pulmonologi dan Kedokteran Respirasi Fakultas Kedokteran
  • Satria Maulana EH, Universitas Sebelas Maret
    Departemen Pulmonologi dan Kedokteran Respirasi Fakultas Kedokteran
  • Ita Haryatie, Universitas Sebelas Maret
    Departemen Pulmonologi dan Kedokteran Respirasi Fakultas Kedokteran
  • Farih Raharjo, Universitas Sebelas Maret
    Departemen Pulmonologi dan Kedokteran Respirasi Fakultas Kedokteran
  • Yusup Subagio Sutanto, Universitas Sebelas Maret
    Departemen Pulmonologi dan Kedokteran Respirasi Fakultas Kedokteran
  • Ana Rima Setijadi, Universitas Sebelas Maret
    Departemen Pulmonologi dan Kedokteran Respirasi Fakultas Kedokteran

References

World Health Organization. World health statistics. Geneva: WHO Press; 2008. p. 10-31.

World Health Organization. Glocal tuberculosis report 2015. 20th ed. Geneva: WHO Press; 2015. p.1-28.

Kementerian Kesehatan Republik Indonesia. Pedoman nasional pengendalian tuberkulosis. Jakarta: Kementerian kesehatan RI; 2016. p. 1-210.

Singh VK, Chandra S, Kumar S, Pangtey G, Mohan A, Guleria R. A common medical error: Lung cancer misdiagnosed as sputum negative tuberculosis. Asian Pacific J Cancer Prev. 2009;10(3):335–8.

Wallace WD, Travis WD. Pathology: malignant and interstitial lung diseases. In: Broaddus VC, Mason RJ, Ernst JD, King TE, Lazarus SC, Murray JF, et al., editors. Murray & nadel’s textbook of respiratory medicine. 6th ed. Philadelphia: Elsevier Saunders; 2016. p. 225–50.

Perhimpunan Dokter Paru Indonesia. Tuberkulosis pedoman diagnosis dan penetalaksanaan di Indonesia. Jakarta: Perhimpunan Dokter Paru Indonesia; 2011. p. 1-66.

Hubbard R. Epidemiology of lung cancer. In: Maskell N, Millar A, editors. Oxford desk reference: respiratory medicine. New York: Oxford university press Inc.; 2009. p. 282–3.

Cruz CS Dela, Tanoue LT, Matthay RA. Epidemiology of lung cancer. In: Grippi MA, Elias JA, Fishman JA, Kotloff RM, Pack AI, Senior RM, editors. Fishman’s pulmonary diseases and disorders. 5 th. United States: McGraw-Hill companies, Inc; 2015. p. 1667–83.

Blagden SP, Charman SC, Sharples LD, Magee LRA, Gilligan D. Performance status score: do patients and their oncologists agree. Br J Cancer. 2003;89(6):1022–7.

Das DK. Age and sex distribution in malignant and tuberculous serous effusions: A study of 127 patients and review of the literature. Geriatr Gerontol Int. 2015;15(9):1143–50.

Downloads

Published

2017-10-17

Issue

Section

Original Article

Similar Articles

1-10 of 209

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 > >>